Author of the publication

The Minimally-Invasive Oral Glucose Minimal Model: Estimation of Gastric Retention, Glucose Rate of Appearance, and Insulin Sensitivity From Type 1 Diabetes Data Collected in Real-Life Conditions.

, , , , and . IEEE Trans. Biomed. Eng., 71 (3): 977-986 (March 2024)

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

 

Other publications of authors with the same name

Modeling Subcutaneous Absorption of Fast-Acting Insulin in Type 1 Diabetes., , and . IEEE Trans. Biomed. Eng., 65 (9): 2079-2086 (2018)Incorporating Long-Acting Insulin Glargine Into the UVA/Padova Type 1 Diabetes Simulator for In Silico Testing of MDI Therapies., , , , , and . IEEE Trans. Biomed. Eng., 66 (10): 2889-2896 (2019)Modeling Between-Subject Variability in Subcutaneous Absorption of a Long-Acting Insulin Glargine 100 U/mL by a Nonlinear Mixed Effects Approach., , and . EMBC, page 4226-4229. IEEE, (2021)Modeling Subcutaneous Absorption of Long-Acting Insulin Glargine in Type 1 Diabetes., , , , , and . IEEE Trans. Biomed. Eng., 67 (2): 624-631 (2020)A Model of Acetaminophen Pharmacokinetics and its Effect on Continuous Glucose Monitoring Sensor Measurements., , , , and . EMBC, page 159-162. IEEE, (2018)The Minimally-Invasive Oral Glucose Minimal Model: Estimation of Gastric Retention, Glucose Rate of Appearance, and Insulin Sensitivity From Type 1 Diabetes Data Collected in Real-Life Conditions., , , , and . IEEE Trans. Biomed. Eng., 71 (3): 977-986 (March 2024)In Silico Cloning of Target Type 2 Diabetes Population for Treatments Development and Decision Support*., , and . EMBC, page 5111-5114. IEEE, (2020)Physiology-Based Run-to-Run Adaptation of Insulin to Carbohydrate Ratio Improves Type 1 Diabetes Therapy: Results from an In Silico Study., , and . ACC, page 4124-4129. IEEE, (2019)Long-acting Insulin in Diabetes Therapy: In Silico Clinical Trials with the UVA/Padova Type 1 Diabetes Simulator*., , , , , and . EMBC, page 4905-4908. IEEE, (2018)